Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Balding and low testosterone increase risk of urinary stones.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

Cyclosporin A does not change sex hormone levels.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Androgen levels increase with puberty and are linked to sexual hair development.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.